Rahul Saxena

Dr. Rahul Saxena

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2022 in Journal of Pharmaceutical Negative Results
Verified
Journal Article
Open access
PDF file
VSVandana Singh
Vandana Singh
EKEkta Kasana
Ekta Kasana
JBJyoti Batra
Jyoti Batra
HSHarsh Sable
Harsh Sable
RSRahul Saxena
Rahul Saxena
Antimicrobial resistance is one of the greatest dangers to public health on a worldwide scale. Even though the evolution of resistant microbes is a naturally occurring phenomenon, the excessive or improper use of antimicrobial agents has significantly impacted resistance evolution. Effective treatment techniques can be guided by rapid diagnostic tests of these resistance to detect drug-resistant microorganisms quickly, assess antimicrobial susceptibility, and bacterial infections from differentiate viral. In addition, quick diagnostic test could assist epidemiological surveillance by monitoring developing resistance to pathogenic pathogens and their transmission. Methods for AMR detection, and surveillance, includes Microscopy, PCR, DNA microarray, matrix-assisted laser desorption,Pyrosequencing, NAAT, whole genome sequencing, Immuno detection, spectroscopy, FTIR, Biosensor, and microfluidics technology. The AMR turmoil necessitates a concerted effort from researchers to improve the current approaches for treatment and diagnosis by developing novel techniques that circumvent the limitations and drawbacks of the best alternatives and conventional AST methods. This review mainly summarizes the different emerging diagnostic techniques used to detect antibiotic resistance and the mechanism of drug resistance. These emerging diagnostic strategies might improve medication development strategies and the surveillance of resistance evolution.

31 August 2024 in Asian Journal of Current Research
Verified
Journal Article
Closed access
PDF file
ASAjit Pal Singh
Ajit Pal Singh
RSRahul Saxena
Rahul Saxena
SSSuyash Saxena
Suyash Saxena
Virtual assistants are rapidly transforming the educational landscape. These AI-driven tools offer personalized support, enhancing student engagement and improving learning outcomes. Virtual assistants can answer questions instantly, clarify complex concepts, and create tailored study plans. By automating routine tasks and providing on-demand assistance, they free up educators to concentrate on more advanced instructional activities. Moreover, virtual assistants can analyze student performance data to pinpoint areas needing improvement and suggest targeted interventions. This data-driven approach allows educators to offer customized support and adjust their teaching strategies accordingly. While virtual assistants can't fully replace human interaction, they serve as valuable complements to traditional teaching methods, helping to foster a more dynamic and effective learning environment.

3 November 2023
Verified
Book Chapter
Closed access
VSVandana Singh
Vandana Singh
AVAnkush Verma
Ankush Verma
ACAmit Pratap Singh Chouhan
Amit Pratap Singh Chouhan
RSRahul Saxena
Rahul Saxena
SKSanjana Koranga
Sanjana Koranga
THTakreem Husain
Takreem Husain
Nanomaterials' unique physicochemical features make them suitable for biological applications such medication delivery, imaging, and tissue engineering. However, there is growing concern regarding their safety and toxicity due to their small size and high surface area, which can result in unanticipated interactions with biological systems. Studies have demonstrated that cationic nanoparticles exhibit a propensity to interact with cellular membranes and elicit oxidative stress, while anionic nanoparticles have a tendency to accumulate within lysosomes and trigger inflammatory responses. Numerous methods have been developed to evaluate the safety and toxicity of nanomaterials, such as in-vitro, in-vivo assays, computational modeling, etc. Nanomaterials in medical sciences are subject to regulatory scaffolds that give guidelines/ policies for safety assessment and risk management, nonetheless more research is required to entirely comprehend the possible long-term effects or interactions of nanoparticles with other environmental elements. Request access from your librarian to read this chapter's full text.

25 February 2025 in Journal of Biochemistry International
Verified
Journal Article
Open access
PDF file
ASAjit Pal Singh
Ajit Pal Singh
RSRahul Saxena
Rahul Saxena
SSSuyash Saxena
Suyash Saxena
Recent advances in cytopathology, particularly with the use of molecular and cellular technology, have significantly improved the accuracy and thoroughness of disease diagnosis. This advancement is enhancing the capacity to identify and characterise numerous illnesses, including cancer, at the molecular level, facilitating more precise diagnoses, early disease detection, and tailored treatment approaches. The integration of genomic methodologies, including next-generation sequencing (NGS), polymerase chain reaction (PCR), and fluorescence In situ hybridisation (FISH), has enabled cytopathologists to detect genetic mutations, chromosomal anomalies, and gene expression patterns essential for comprehending tumour biology and informing treatment strategies. Single-cell analysis helps us understand the genetic and phenotypic differences within cancer cells. It reveals unique groups of cells that play a role in how the disease grows and why some treatments don’t work. Innovative tools, such as liquid biopsy, are revolutionising the non-invasive identification and surveillance of cancer, facilitating real-time monitoring of minimal residual disease (MRD) and metastatic advancement. Digital pathology and artificial intelligence (AI) are changing the way we work by making it faster and more accurate to analyse images. They help reduce personal bias and improve the reliability of diagnoses. The integration of new technology in cytopathology significantly influences clinical practice, enabling earlier detection, personalised therapies, and enhanced patient outcomes. The continuous investigation and enhancement of these techniques is expected to propel future advancements in precision diagnosis and personalised treatment, defining the forthcoming era of healthcare.

27 August 2024
Verified
Book Chapter
Closed access
RSRahul Saxena
Rahul Saxena
GKGoutami Katage
Goutami Katage
Chandan KumarChandan Kumar
Chandan Kumar
NPNawaj Mehtab Pathan
Nawaj Mehtab Pathan
MBMohammadazar Nisar Bargir
Mohammadazar Nisar Bargir
Healthcare providers heavily rely on accurate and comprehensive documentation to ensure the best possible care for patients, plan treatments, and conduct research. However, traditional documentation methods are often time-consuming, prone to errors, and generate massive amounts of paperwork. Fortunately, AI has the potential to revolutionize healthcare documentation and streamline the process for healthcare providers. AI can automate various aspects of healthcare documentation, such as transcription, coding, and billing, by leveraging machine learning algorithms and natural language processing. AI-driven solutions can also enhance the accuracy and completeness of patient records by detecting patterns that may not be easily noticeable to healthcare providers. This can lead to more informed decision-making and personalized treatment plans for patients. AI can standardize and structure data, facilitating seamless information exchange between different healthcare systems and enhancing interoperability. Overall, the integration of AI in healthcare documentation holds significant potential for transforming healthcare delivery and offering more efficient, accurate, and integrated care.

15 June 2024 in International Journal of Clinical Biochemistry and Research
Verified
Journal Article
Open access
PDF file
RSRahul Saxena
Rahul Saxena
SSSuyash Saxena
Suyash Saxena
ASAjit Pal Singh
Ajit Pal Singh
Neelesh Kumar MauryaNeelesh Kumar Maurya
Neelesh Kumar Maurya
Diabetes Mellitus (DM) goes beyond just a lack of insulin. Type 2 Diabetes Mellitus (T2DM) is heavily influenced by insulin resistance. Cells become less responsive to insulin’s signal to absorb glucose, leading to high blood sugar levels. Excess body fat, particularly around the abdomen, and a sedentary lifestyle are ley culprits for this resistance. The pancreas struggles to keep up with the demand for insulin in T2DM. Initially, it compensates by producing more, but over time, this ability declines due to factors like genetics and high blood sugar levels. Glucagon, normally working opposite insulin becomes imbalanced in T2DM. Its levels rise, further promoting glucose production and worsening hyperglycemia. The contributing factors include fasting, high protein diet, and pancreatic issues. The liver’s ability to regulate glucose production is impaired in T2DM. This dysregulation leads to the excessive release of glucose into the bloodstream, contributing to chronic hyperglycemia. Certain genetic disorders affecting carbohydrate metabolism can increase the risk of diabetes. These disorders can lead to changes that mimic pre-diabetes, further contributing to insulin resistance. In T2DM, increased lipolysis releases excessive free fatty acids (FFAs) into the blood stream. These FFAs worsen insulin resistance and damage insulin-producing cells, further exacerbating hyperglycemia. Obesity, with its high fat stores and increased lipolysis, is a major risk factor. The kidneys play a crucial role in reabsorbing filtered glucose from the urine. In T2DM, this reabsorption might be heightened contributing to hyperglycemia. Additionally, chronic kidney disease can impair glucose metabolism, potentially impacting diabetes management. While insulin deficiency plays a role, diabetes is a complex interplay of factors. Unravelling the intricate dance between insulin, glucagon, the liver and cellular responses is crucial for effective management and prevention of diabetes-related complications. This review delves into the intricate metabolic reasons behind this condition, focusing in Type 2 Diabetes Mellitus (T2DM).